Validation of the 2016 Revisions to the WHO Classification in Lower-Risk Myelodysplastic Syndrome

Benzer Materyaller

• Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
  Yazar:: Kanagal-Shamanna, Rashmi, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report
  Yazar:: Burgos, Sebastian, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
  Yazar:: Kanagal-Shamanna, Rashmi, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Incidental identification of inv(16)(p13.1q22)/CBFB–MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy
  Yazar:: Quesada, Andrés E., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Multiparameter Analysis of the “Off-Target Effects” of Dasatinib on Bone Homeostasis in Patients with Newly Diagnosed Chronic Myelogenous Leukemia
  Yazar:: Hoehn, Daniela, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)